Last edition
News about "Cospiaq "
Torrent Pharma Signs Deal with Boehringer Ingelheim to Acquire Three Anti-Diabetes Brands
Empagliflozin is a novel sodium-glucose co-transporter-2 (SGLT-2) inhibitor that is indicated for glycemic control in adults with type 2 diabetes mellitus.
Cospiaq | 09/12/2024 | By Aishwarya | 580
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members